Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Guido J.R. Zaman(GlaxoSmithKline (Netherlands)), Piet Borst(The Netherlands Cancer Institute), Ronald P.J. Oude Elferink(Amsterdam University Medical Centers), Henk Dekker(Oncode Institute), Jos H. Beijnen(The Netherlands Cancer Institute), Coen C. Paulusma(Oncode Institute), Frank Baas(Leiden University Medical Center), J. Lankelma(Unknown), Olaf van Tellingen(Dutch Cancer Society)
Proceedings of the National Academy of Sciences
August 15, 1995
10.1073/pnas.92.17.7690
Cited by 502

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
|Proceedings of the National Academy of Sciences|1994|691